Jiangbo Pharmaceuticals, Inc.(fka JGBO)

[996]

Traderfan I think you are right on the fact that JGBO themselves called 2010 a transition year and therefore we are having a little stagnation. I remember they made a statement that their prediction for FY 2010 only included the drugs they were selling already: the new drugs that are expected hadn't been included. So my bet is we will see better than predicted revenues (and thus net income).
First things first: uplisting. I think I've read somewhere that review of the application could take 6-8 weeks. So Biggreen's guess would be very plausible.